Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 or older of any race who has been identified as having a higher-than-average risk of developing breast cancer and has been referred to MD Anderson Cancer Center (MDACC).
- Your higher risk may be based on a lifetime risk calculation of more than 20%, a tissue finding such as certain types of abnormal breast cells (lobular neoplasia, atypical ductal hyperplasia, or atypia), or a gene mutation known to increase breast cancer risk.
- You are already scheduled to have a breast MRI and are willing to also have a second breast imaging test (called MBI) within a two-week period.
- You are willing to have a biopsy if anything unusual is found on either scan.
- You are willing to fill out a short survey about your experience with both tests after they are completed.
- If you do not speak English, a language interpreter can be provided to help you.
- You are able to give written consent to take part in the study.
Who may not be able to join:
- You are currently pregnant, because the MBI scan requires an injection of a small amount of radioactive material, which is not safe during pregnancy.
- You are currently pregnant, because the MRI scan also requires an injection of a dye called gadolinium, which is also not considered safe during pregnancy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To establish the diagnostic performance of Molecular Breast Imaging (MBI) to breast Magnetic Resonance Imaging (MRI) in women who are at high risk of developing breast cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.